Study 4: Stier 2013, human safety analysis Citation: Stier H., Vos E., Kenley D
Clinical trial safety reports and adverse events Clinical trials on GHK-CU have reported few adverse events, with most being mild and transient in nature
The taste is not very pleasant, so if your pet is picky, give it by mouth
The 3 mL reaction mixture was composed of 0.1 mL of enzyme extract (0.1 mL of distilled water for the control), 1.5 mL of 50 mM phosphate buffer (pH 7.8), 0.3 mL of 0.1 mM ethylenediaminetetraacetic acid (EDTA), 0.3 mL of 130 mM L-methionine, 0.3 mL of 0.75 mM NBT, 0.3 mL of 0.02 mM riboflavin, and 0.5 mL of distilled water
NNMT catalyzes the methylation of nicotinamide (vitamin B3) using S-adenosylmethionine (SAM) as the methyl donor, producing 1-methylnicotinamide (1-MNA) and S-adenosylhomocysteine
It is worth mentioning that ginsenoside Rc as well as Rb1 and Re can also inhibit coronary vascular dysfunction ( Hypertension There is substantial evidence that ginsenosides are beneficial in the treatment of hypertension, not only does ginseng lower blood pressure, it also acts as a heart protector (Nagar et al., 2016)